Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study

BACKGROUND: Allergic rhinoconjunctivitis (ARC) due to birch pollen is a growing health concern in Europe. Here, we report the efficacy and safety of 300IR birch pollen sublingual solution administered discontinuously for 2 consecutive years to patients with birch-associated allergic rhinoconjunctivi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Worm, Margitta, Rak, Sabina, de Blay, Frédéric, Malling, Hans-Jorgen, Melac, Michel, Cadic, Véronique, Zeldin, Robert K
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3928083/
https://ncbi.nlm.nih.gov/pubmed/24517417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-7022-4-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items